CAJ | 학술논문

目的：：研究替莫唑胺联合放疗治疗胶质母细胞瘤的成本-效果。方法：根据临床试验( EORTC26981/22981-NCIC CE3)数据，结合我国医疗费用及消费水平，进行成本-效果分析，并对结果进行敏感度分析。结果：替莫唑胺联合放疗方案相较于单纯放疗方案，每例患者总生存期增加1个月，需多花费人民币58959.7元。结论：替莫唑胺联合放疗方案相对于单纯放疗方案不具有成本-效果优势。
목적：：연구체막서알연합방료치료효질모세포류적성본-효과。방법：근거림상시험( EORTC26981/22981-NCIC CE3)수거，결합아국의료비용급소비수평，진행성본-효과분석，병대결과진행민감도분석。결과：체막서알연합방료방안상교우단순방료방안，매례환자총생존기증가1개월，수다화비인민폐58959.7원。결론：체막서알연합방료방안상대우단순방료방안불구유성본-효과우세。
To study the cost-effectiveness of temozolomide combined with radiotherapy in the treatment of glioblasto-ma. Methods:According to the clinical trial data, cost-effectiveness and sensitivity of the results was analyzed based on the domestic cost and consumption level. Results:Temozolomide combined with radiotherapy could prolong one month of overall survival with the additional cost of RMB 58 959. 7 yuan in each case when compared with radiotherapy alone. Conclusion:Temozolomide combined with radiotherapy has no advantage on cost-effectiveness when compared with radiotherapy alone.